Evaluation of the Early Bactericidal Activity of Tedizolid and Linezolide Against Mycobacterium Tuberculosis (TEDITUB)

NCT05534750 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

60

Enrollment

OTHER

Sponsor class

Conditions

Tuberculosis
Multidrug Resistant Tuberculosis

Interventions

DRUG: Tedizolid arm (SIVEXTRO®)
DRUG: Linezolid arm (ZYVOXID®)
DRUG: Standard quadruple therapy arm

Sponsor

Assistance Publique - Hôpitaux de Paris